These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 26088116)

  • 41. Pharmacokinetics and clinical use of flumazenil (Ro 15-1788).
    Klotz U; Kanto J
    Clin Pharmacokinet; 1988 Jan; 14(1):1-12. PubMed ID: 3127102
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Flumazenil (a specific antagonist of benzodiazepine receptor].
    Ma Zui Xue Za Zhi; 1989 Sep; 27(3):316-8. PubMed ID: 2558269
    [No Abstract]   [Full Text] [Related]  

  • 43. Flumazenil.
    Cone AM; Stott SA
    Br J Hosp Med; 1994 Apr 6-19; 51(7):346-8. PubMed ID: 8081564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Midazolam and other benzodiazepines.
    Olkkola KT; Ahonen J
    Handb Exp Pharmacol; 2008; (182):335-60. PubMed ID: 18175099
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Benzodiazepine receptor antagonists for acute and chronic hepatic encephalopathy.
    Als-Nielsen B; Kjaergard LL; Gluud C
    Cochrane Database Syst Rev; 2001; (4):CD002798. PubMed ID: 11687160
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allosteric uncoupling and up-regulation of benzodiazepine and GABA recognition sites following chronic diazepam treatment of HEK 293 cells stably transfected with alpha1beta2gamma2S subunits of GABA (A) receptors.
    Pericić D; Strac DS; Jembrek MJ; Vlainić J
    Naunyn Schmiedebergs Arch Pharmacol; 2007 May; 375(3):177-87. PubMed ID: 17377772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reversal of central nervous system effects by flumazenil after intravenous conscious sedation with midazolam: report of a multicenter clinical study. The Flumazenil in Intravenous Conscious Sedation with Midazolam Multicenter Study Group I.
    Clin Ther; 1992; 14(6):861-77. PubMed ID: 1286495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Discriminative stimulus effects of omega (BZ) receptor ligands: correlation with in vivo inhibition of [3H]-flumazenil binding in different regions of the rat central nervous system.
    Sanger DJ; Benavides J
    Psychopharmacology (Berl); 1993; 111(3):315-22. PubMed ID: 7870969
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical experience in benzodiazepine antagonist].
    Hung DZ; Deng JF; Tsai WJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 Feb; 47(2):121-5. PubMed ID: 1672103
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic exposure of cells expressing recombinant GABAA receptors to benzodiazepine antagonist flumazenil enhances the maximum number of benzodiazepine binding sites.
    Pericić D; Lazić J; Jembrek MJ; Strac DS; Rajcan I
    Life Sci; 2004 Dec; 76(3):303-17. PubMed ID: 15531382
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anterograde amnesia in triazolam overdose despite flumazenil treatment: a case report.
    Hung DZ; Tsai WJ; Deng JF
    Hum Exp Toxicol; 1992 Jul; 11(4):289-90. PubMed ID: 1354979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Changes in hippocampal GABAA receptor subunit composition in bipolar 1 disorder.
    Dean B; Scarr E; McLeod M
    Brain Res Mol Brain Res; 2005 Aug; 138(2):145-55. PubMed ID: 15950312
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Brain GABA and benzodiazepine receptors in hepatic encephalopathy.
    Butterworth RF
    Rev Invest Clin; 1990 Jul; 42 Suppl():137-40. PubMed ID: 19256153
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Is There a Place for Off-Label Pharmacotherapy in Cannabis Use Disorder? A Review on Efficacy and Safety.
    Laprevote V; Schwan R; Schwitzer T; Rolland B; Thome J
    Curr Pharm Des; 2015; 21(23):3298-305. PubMed ID: 26088109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resuscitative effect of a gamma-aminobutyric acid B receptor antagonist on gamma-hydroxybutyric acid mortality in mice.
    Carai MA; Colombo G; Gessa GL
    Ann Emerg Med; 2005 Jun; 45(6):614-9. PubMed ID: 15940094
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans.
    Bansky G; Meier PJ; Riederer E; Walser H; Ziegler WH; Schmid M
    Gastroenterology; 1989 Sep; 97(3):744-50. PubMed ID: 2546850
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Flumazenil-induced ballism.
    Kim JS; Ko SB; Choi YB; Lee KS
    J Korean Med Sci; 2003 Apr; 18(2):299-300. PubMed ID: 12692435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Flumazenil for hepatic encephalopathy grade III and IVa in patients with cirrhosis: an Italian multicenter double-blind, placebo-controlled, cross-over study.
    Barbaro G; Di Lorenzo G; Soldini M; Giancaspro G; Bellomo G; Belloni G; Grisorio B; Annese M; Bacca D; Francavilla R; Barbarini G
    Hepatology; 1998 Aug; 28(2):374-8. PubMed ID: 9695999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Involvement of diazepam-insensitive benzodiazepine receptors in the suppression of DOI-induced head-twitch responses in diabetic mice.
    Miyata S; Hirano S; Kamei J
    Psychopharmacology (Berl); 2006 May; 186(1):1-6. PubMed ID: 16555059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reversal or reduction of glutamate and GABA transport in CNS pathology and therapy.
    Allen NJ; Káradóttir R; Attwell D
    Pflugers Arch; 2004 Nov; 449(2):132-42. PubMed ID: 15338308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.